iSpecimen Inc. (ISPC)

Nasdaq · Services-Commercial Physical & Biological Research · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 5 signals for iSpecimen Inc.. Most notable: 2026-08-31: Filed 8-K disclosing director or officer change; 2026-08-07: Filed 8-K disclosing material agreement; 2026-08-11: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing material agreement
  7. Material 8-K filing
    Filed 8-K disclosing director or officer change
  8. Material 8-K filing
    Filed 8-K disclosing material agreement
  9. Material 8-K filing
    Filed 8-K disclosing material agreement
  10. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

No insider transactions on record.

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings